secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001493152-23-027585
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical completes acquisition of Surgalign's hardware and biologics business for $5 million
--------------------------------------------------------------------------------

- Xtant Medical acquired certain assets of Surgalign Holdings, Inc. for $5 million cash plus assumed liabilities under Bankruptcy Court supervision.
- The acquisition includes inventory, intellectual property, contracts, equipment, and equity of Surgalign's international subsidiaries.
- Xtant entered into Fourth Amendments to its credit agreements with MidCap Financial Trust and MidCap Funding IV Trust to permit the transaction.
- Xtant issued a press release announcing closing and reiterated 2023 revenue guidance of $75-77 million.
- The closing follows a Sale Order issued by the U.S. Bankruptcy Court for the Southern District of Texas on August 9, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223027585/0001493152-23-027585-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223027585/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-027585

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer